News

As part of our focus and direction, Pendopharm proudly unveils its new logo and website. Graphically, our new logo conveys flexibility and dynamic movement while capturing our three distinct product portfolios: Rx, OTC and BTC. We invite you to navigate through our new website and we hope that you will find it as informative as we enjoyed creating it. [Read More]

Pharmascience Inc. acquires Aegera Therapeutics Inc., a
Montreal-based clinical-stage biotechnology company focused on developing targeted therapeutics, primarily in oncology. [Read More]